Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum Toxin A vs Corticosteroid for Refractory Plantar Fasciitis
NCT05367271Phase 3Completed
- Sponsor
- Western Institute for Veterans Research
- Start
- Aug 2022
- Primary completion
- Sep 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in plantar fasciitis, sponsored by Western Institute for Veterans Research. Started Aug 2022; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
plantar fasciitis
Beyond the preview
Go deeper on NCT05367271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367271.